Profil
Jennifer Ziolkowski formerly worked at TransMedics, Inc., as Controller & Senior Director-Finance from 2007 to 2008, Imaging Systems, Inc., as Finance Director from 2008 to 2010, Philips Electronics North America Corp., as Head-North America Sales Operations from 2015 to 2017, Solid Biosciences, Inc., as Chief Financial Officer & Treasurer from 2017 to 2021, and Vigil Neuroscience, Inc., as Chief Financial Officer from 2020 to 2025.
Ms. Ziolkowski received her undergraduate degree from Boston College.
Anciens postes connus de Jennifer Ziolkowski
| Sociétés | Poste | Fin |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Directeur Financier/CFO | 05/08/2025 |
| SOLID BIOSCIENCES INC. | Directeur Financier/CFO | 29/01/2021 |
Philips Electronics North America Corp.
Philips Electronics North America Corp. Electronics/AppliancesConsumer Durables Manufactures and distributes television, video, audio and set-top boxes | Corporate Officer/Principal | 01/05/2017 |
Imaging Systems, Inc. | Directeur Financier/CFO | 01/01/2010 |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Directeur Financier/CFO | 01/01/2008 |
Formation de Jennifer Ziolkowski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Philips Electronics North America Corp.
Philips Electronics North America Corp. Electronics/AppliancesConsumer Durables Manufactures and distributes television, video, audio and set-top boxes | Consumer Durables |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Health Technology |
Imaging Systems, Inc. | |
Solid Biosciences, Inc.
Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
















